112 related articles for article (PubMed ID: 12065728)
1. Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade.
Lynch JJ; Salata JJ; Wallace AA; Stump GL; Gilberto DB; Jahansouz H; Liverton NJ; Selnick HG; Claremon DA
J Pharmacol Exp Ther; 2002 Jul; 302(1):283-9. PubMed ID: 12065728
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmia.
Lynch JJ; Houle MS; Stump GL; Wallace AA; Gilberto DB; Jahansouz H; Smith GR; Tebben AJ; Liverton NJ; Selnick HG; Claremon DA; Billman GE
Circulation; 1999 Nov; 100(18):1917-22. PubMed ID: 10545437
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of I(Ks): potential for antiarrhythmic therapy.
Salataa JJ; Selnickb HG; Lynch JJ
Curr Med Chem; 2004 Jan; 11(1):29-44. PubMed ID: 14754424
[TBL] [Abstract][Full Text] [Related]
4. Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current IKs by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)- 2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide.
Selnick HG; Liverton NJ; Baldwin JJ; Butcher JW; Claremon DA; Elliott JM; Freidinger RM; King SA; Libby BE; McIntyre CJ; Pribush DA; Remy DC; Smith GR; Tebben AJ; Jurkiewicz NK; Lynch JJ; Salata JJ; Sanguinetti MC; Siegl PK; Slaughter DE; Vyas K
J Med Chem; 1997 Nov; 40(24):3865-8. PubMed ID: 9397166
[No Abstract] [Full Text] [Related]
5. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
[TBL] [Abstract][Full Text] [Related]
6. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.
Lynch JJ; Wallace AA; Stump GL; Stupienski RF; Kothstein T; Gehret JR
J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544
[TBL] [Abstract][Full Text] [Related]
7. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
8. IKs protects from ventricular arrhythmia during cardiac ischemia and reperfusion in rabbits by preserving the repolarization reserve.
Guo X; Gao X; Wang Y; Peng L; Zhu Y; Wang S
PLoS One; 2012; 7(2):e31545. PubMed ID: 22384037
[TBL] [Abstract][Full Text] [Related]
9. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
[TBL] [Abstract][Full Text] [Related]
10. Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Takatsuki S; Mitamura H; Kanki H; Sueyoshi K; Ogawa S
J Cardiovasc Pharmacol; 2000 Jun; 35(6):914-8. PubMed ID: 10836726
[TBL] [Abstract][Full Text] [Related]
11. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
12. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization.
Fossa AA; Wisialowski T; Crimin K
J Pharmacol Exp Ther; 2006 Feb; 316(2):498-506. PubMed ID: 16204470
[TBL] [Abstract][Full Text] [Related]
13. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
[TBL] [Abstract][Full Text] [Related]
14. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
Lynch JJ; Coskey LA; Montgomery DG; Lucchesi BR
Am Heart J; 1985 May; 109(5 Pt 1):949-58. PubMed ID: 3993529
[TBL] [Abstract][Full Text] [Related]
15. Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells.
Han W; Wang Z; Nattel S
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1075-80. PubMed ID: 11179049
[TBL] [Abstract][Full Text] [Related]
16. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772
[TBL] [Abstract][Full Text] [Related]
17. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
Ravingerová T; Pancza D; Ziegelhoffer A; Styk J
Physiol Res; 2002; 51(2):109-19. PubMed ID: 12108920
[TBL] [Abstract][Full Text] [Related]
20. Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Houle MS; Altschuld RA; Billman GE
J Appl Physiol (1985); 2001 Oct; 91(4):1627-37. PubMed ID: 11568144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
